Skip to main content
. 2019 Mar 14;50(4):939–946. doi: 10.1161/STROKEAHA.118.023797

Figure 2.

Figure 2.

Inverse probability treatment weighted cumulative incidence of ischemic stroke and intracerebral hemorrhage for warfarin and non–vitamin K antagonist oral anticoagulant (NOAC) treatments.